Latest Regulatory News

Prodigy Gold has won a $112,152 co-funding grant from the Northern Territory Government to drill a 600m hole at its Hyperion Gold Deposit, targeting a major untested geophysical anomaly that could expand the 454,000-ounce resource.

dorsaVi has secured exclusive rights to two key robotics patents from NTU Singapore, filling critical gaps in safety control and data acquisition to expand into collaborative robotics and exoskeleton markets.

Tivan Limited has landed a $141,237 exploration grant from the Northern Territory Government to fund diamond drilling at its Molyhil Tungsten Project, pushing forward its Pre-Feasibility Study and joint venture talks with Sumitomo Corporation.

Rox Resources has secured a fixed-cost EPC contract for its Youanmi processing plant while accelerating underground mining fronts and stockpile development, keeping first gold pour on track for mid-2027.

Peninsula Energy has executed a definitive agreement for a US$30 million senior secured convertible note facility with an affiliate of Soul Patts, advancing its financing strategy for the Lance Uranium Project in Wyoming.

Eden Innovations has wrapped up the second tranche of its $4 million institutional placement, issuing over 14 million shares at 18 cents each. The capital injection finalises the raise announced in April, with shares issued under ASX rules and ranking equally with existing stock.

Tasman Resources has completed the first tranche of a $4 million share placement to fund a larger drilling program at its Parkinson Dam Project in South Australia.

The Supreme Court of Western Australia has approved Genesis Minerals’ acquisition of Magnetic Resources, setting a clear timetable for scheme implementation and ASX trading suspension.

Novo Resources has delivered a maiden inferred resource estimate for the Leven Star Reef within its Belltopper Gold Project, outlining 87,000 ounces of contained gold and setting the stage for further exploration and resource expansion.

Imugene’s off-the-shelf CAR T therapy azer-cel has won FDA Fast Track Designation for relapsed or refractory CLL/SLL and MZL, backed by compelling Phase 1b response rates.

Spenda Limited (ASX:SPX) has kicked off an $8.545 million accelerated entitlement offer at a steep discount, aiming to strengthen its balance sheet, reduce debt, and support its strategic reset towards profitability.

oOh!media is actively engaging with several financial sponsors, including Bain Capital, Pacific Equity Partners, and I Squared Capital, over potential change of control deals, having received conditional non-binding indicative offers.